Insight

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Photo from Thomas Flaig/X

Apr 14, 2024, 06:07

Thomas Flaig: Honored to be able to speak at the annual NCCN meeting on the impact of recent research findings on the treatment of advanced bladder cancer

Thomas Flaig, Vice Chancellor for Research at University of Colorado Denver, shared on X/Twitter:

“Honored to be able to speak at the annual National Comprehensive Cancer Network meeting on the impact of recent research findings on the treatment of advanced bladder cancer – a busy time in the field with several updates to the NCCN bladder cancer guidelines.”

View additional information.
Source: Thomas Flaig/X

advanced bladder cancer Anschutz Medican Campus bladder cancer cancer National Comprehensive Cancer Network NCCN OncoDaily Oncology Thomas Flaig University of Colorado

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage